Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1994 Mar;69(3):577–579. doi: 10.1038/bjc.1994.105

A comparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancer.

A C Rosen 1, P Sevelda 1, M Klein 1, A H Graf 1, M Lahousen 1, A Reiner 1, L Auerbach 1, N Vavra 1, H R Rosen 1
PMCID: PMC1968857  PMID: 8123490

Abstract

Staging and surgical as well as post-operative treatment of primary Fallopian tube carcinoma (FTC) followed the lines established for primary ovarian cancer (OC). In a nationwide retrospective analysis we were able to find a distinct difference between these two tumours. A total of 262 patients, 68 with FTC and 194 with OC, in stage I and II were included into this study. A univariate as well as a multivariate analysis for survival was performed, including factors such as age, histological type, grading and surgical and adjuvant treatment. A significantly poorer outcome (P = 0.0002) for FTC patients with a 5-year survival of 50.8% compared with 77.5% for OC patients was observed. This finding was persistent and independent of any investigated factor, in univariate as well as multivariate analyses. Therefore, we feel that a more aggressive therapeutic approach to the treatment of FTC even in early stages can be recommended. On the other hand, the retrospective character of our study has to be taken into account.

Full text

PDF
577

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barakat R. R., Rubin S. C., Saigo P. E., Chapman D., Lewis J. L., Jr, Jones W. B., Hakes T. B., Markman M., Reichman B., Hoskins W. J. Cisplatin-based combination chemotherapy in carcinoma of the fallopian tube. Gynecol Oncol. 1991 Aug;42(2):156–160. doi: 10.1016/0090-8258(91)90337-5. [DOI] [PubMed] [Google Scholar]
  2. Behr J., Thyselius D., Jäger W., Paterok E. M. Primäres, metastasierendes Tubenkarzinom. Kasuistik und Ubersicht über die aktuelle Therapie. Zentralbl Gynakol. 1990;112(23):1477–1480. [PubMed] [Google Scholar]
  3. Benedet J. L., White G. W., Fairey R. N., Boyes D. A. Adenocarcinoma of the fallopian tube. Experience with 41 patients. Obstet Gynecol. 1977 Dec;50(6):654–657. [PubMed] [Google Scholar]
  4. Böhme M., Donat H., Baumann D. Das primäre Tubenkarzinom. Zentralbl Gynakol. 1992;114(5):244–248. [PubMed] [Google Scholar]
  5. Day T. G., Jr, Gallager H. S., Rutledge F. N. Epithelial carcinoma of the ovary:prognostic importance of histologic grade. Natl Cancer Inst Monogr. 1975 Oct;42:15–21. [PubMed] [Google Scholar]
  6. Dodson M. G., Ford J. H., Jr, Averette H. E. Clinical aspects of fallopian tube carcinoma. Obstet Gynecol. 1970 Dec;36(6):935–939. [PubMed] [Google Scholar]
  7. ENGSTROM L. Primary carcinoma of the fallopian tube. Acta Obstet Gynecol Scand. 1957;36(3):289–305. doi: 10.3109/00016345709161048. [DOI] [PubMed] [Google Scholar]
  8. Engeler V., Reinisch E., Schreiner W. E. Das primäre Tuben-karzinom--Eine klinische Studie an 37 Patientinnen. Geburtshilfe Frauenheilkd. 1981 May;41(5):325–329. doi: 10.1055/s-2008-1036802. [DOI] [PubMed] [Google Scholar]
  9. Erez S., Kaplan A. L., Wall J. A. Clinical staging of carcinoma of the uterine tube. Obstet Gynecol. 1967 Oct;30(4):547–550. [PubMed] [Google Scholar]
  10. Gurney H., Murphy D., Crowther D. The management of primary fallopian tube carcinoma. Br J Obstet Gynaecol. 1990 Sep;97(9):822–826. doi: 10.1111/j.1471-0528.1990.tb02577.x. [DOI] [PubMed] [Google Scholar]
  11. HU C. Y., TAYMOR M. L., HERTIG A. T. Primary carcinoma of the fallopian tube. Am J Obstet Gynecol. 1950 Jan;59(1):58-67, illust. doi: 10.1016/0002-9378(50)90341-3. [DOI] [PubMed] [Google Scholar]
  12. Hanton E. M., Malkasian G. D., Jr, Dahlin D. C., Pratt J. H. Primary carcinoma of the fallopian tube. Am J Obstet Gynecol. 1966 Mar 15;94(6):832–839. [PubMed] [Google Scholar]
  13. Henderson S. R., Harper R. C., Salazar O. M., Rudolph J. H. Primary carcinoma of the fallopian tube: difficulties of diagnosis and treatment. Gynecol Oncol. 1977 Jun;5(2):168–179. doi: 10.1016/0090-8258(77)90021-x. [DOI] [PubMed] [Google Scholar]
  14. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966 Mar;50(3):163–170. [PubMed] [Google Scholar]
  15. Morris M., Gershenson D. M., Burke T. W., Kavanagh J. J., Silva E. G., Wharton J. T. Treatment of fallopian tube carcinoma with cisplatin, doxorubicin, and cyclophosphamide. Obstet Gynecol. 1990 Dec;76(6):1020–1024. [PubMed] [Google Scholar]
  16. Pakisch B., Poschauko J., Stücklschweiger G., Poier E., Lahousen M., Pickel H., Kohek P., Klug P., Hackl A. Die Behandlung des primären Karzinoms der Tuba Fallopii. Geburtshilfe Frauenheilkd. 1990 Aug;50(8):593–596. doi: 10.1055/s-2008-1026307. [DOI] [PubMed] [Google Scholar]
  17. Pfeiffer P., Mogensen H., Amtrup F., Honore E. Primary carcinoma of the fallopian tube. A retrospective study of patients reported to the Danish Cancer Registry in a five-year period. Acta Oncol. 1989;28(1):7–11. doi: 10.3109/02841868909111173. [DOI] [PubMed] [Google Scholar]
  18. Phelps H. M., Chapman K. E. Role of radiation therapy in treatment of primary carcinoma of the uterine tube. Obstet Gynecol. 1974 May;43(5):669–673. [PubMed] [Google Scholar]
  19. Roberts J. A., Lifshitz S. Primary adenocarcinoma of the fallopian tube. Gynecol Oncol. 1982 Jun;13(3):301–308. doi: 10.1016/0090-8258(82)90067-1. [DOI] [PubMed] [Google Scholar]
  20. Rosen A., Klein M., Lahousen M., Graf A. H., Rainer A., Vavra N. Primary carcinoma of the fallopian tube--a retrospective analysis of 115 patients. Austrian Cooperative Study Group for Fallopian Tube Carcinoma. Br J Cancer. 1993 Sep;68(3):605–609. doi: 10.1038/bjc.1993.394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Yoonessi M. Carcinoma of the fallopian tube. Obstet Gynecol Surv. 1979 Apr;34(4):257–270. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES